ISSN: 2300-9705
eISSN: 2353-2807
OAI
DOI: 10.18276/cej.2022.2-07
Issue archive /
Vol. 38, No. 2/2022
Obesity, Physical Activity and Prostate Cancer: An Overview
| Authors: |
Joanna
Kruk
Faculty of Physical Culture and Health, University of Szczecin, Poland Joshua Bernstein
A.T. Still University of Health Sciences, College of Graduate Health Studies, Kirksville, Missouri, USA Basil H. Aboul-Enein
Johnson & Wales University, College of Health & Wellness, Department of Health Science, Providence, Rhode Island, USA; London School of Hygiene & Tropical Medicine, Faculty of Public Health and Policy, London, United Kingdom |
| Keywords: | Overweight obesity prostate cancer inflammation physical activity |
| Data publikacji całości: | 2022 |
| Page range: | 21 (71-91) |
Abstract
Obesity and a lack of sufficient physical activity (PA) are recognized as risk factors for most civilization diseases, including cancer. This study synthesized the current evidence evaluating the relationship between excess body weight and prostate cancer (PCa) in the relation to the disease risk, progression, and mortality, and identifies biological plausibility of the association. We also estimated the importance of PA in intentional body weight loss.
Several electronic major databases to identify eligible articles were searched until March 2022. A total 22 observational articles, the literature on the underlying biological mechanisms, and the crucial evidence of a role of PA in body weight maintenance and reduction were reviewed.
The available knowledge suggests that association between body mass index and PCa is conflicting. However, the most research consistently shown that overweight/obesity was associated with higher risk of high-grade PCa and dying of PCa.
Overweight/obesity can promote high-grade PCa through increased levels of secreted adipokines, increased formation of proinflammatory agents, and reduced concentration of adiponectin, among others. Being obese may by also linked with a higher risk of mortality. Exercise can decrease these health consequences related with obesity and may be effective in reduction of PCa-specific mortality, however, there are relative few studies on PA and PCa prevention among obese individuals.
Download file
Article file
Bibliography
| 1. | Aggarwal, V., Tuli, H.S., Varol, A. Thakral, F., Yerer, M.B., Sak, K., Varol, M., Jain, A., Khan, M.A., Sethi, G. (2019). Role of reactive oxygen species in cancer progression: Molecular mechanisms and recent advancements. Biomolecules, 9 (11), 735. DOI:10.3390/biom9110735. |
| 2. | Allott, E.H., Masko, E.M., Freedland S.J. (2013). Obesity and prostate cancer: weighing the evidence. Eur Urol, 63, 800–809. DOI:10.1016/j.eururo.2012.11.013. |
| 3. | Bai, P.D., Hu, M.B., Xu, H., Zhu, W.H., Hu, J.M., Yang, T., Jiang, H. W., Ding, Q. (2015). Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis. World J Surg Oncol, 5 (13), 311. DOI:10.1186/s12957-015-0725-0. |
| 4. | Bashir, M.N., Ahmad, M.R., Malik, A. (2014). Risk factors of prostate cancer: a case-control study in Faisalabad, Pakistan. Asian Pac J Cancer Prev, 15, 10237-10240. DOI:10.7314/apjcp.2014.15.23.10237. |
| 5. | Baumann, F. T., Zopf, E. M., Bloch, W. (2012). Clinical exercise interventions in prostate cancer patients - a systematic review of randomized controlled trials. MASCC, 20, 221–233. DOI:10.1007/s00520-011-1271-0. |
| 6. | Benke, I.N., Leitzmann, M.F., Behrens, G., Schmid, D. (2018). Physical activity in relation to risk of prostate cancer: a systematic review and meta-analysis. Ann Oncol, 29 (5), 1154-1179. DOI:10.1093/annonc/mdy073. |
| 7. | Berger, F. F., Leitzmann, M. F., Hillreiner, A., Sedlmeier, A. M., Prokopidi-Danisch, M. E., Burger, M., Jochem, C. (2019). Sedentary behavior and prostate cancer: A systematic review and meta-analysis of prospective cohort studies. Cancer Prev Res., 12 (10), 675–688. DOI:10.1158/1940-6207.CAPR-19-0271. |
| 8. | Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68 (6), 394–424. DOI:10.3322/caac.21492. |
| 9. | Calle, E.E., Kaaks, R. (2004). Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer, 4, 579–591. DOI:10.1038/nrc1408. |
| 10. | Campos, C., Sotomayor, P., Jerez, D., González, J., Schmidt, C.B., Schmidt, K., Banzer, W., Godoy, A.S. (2018). Exercise and prostate cancer: From basic science to clinical applications. Prostate, 78 (9), 639–645. DOI:10.1002/pros.23502. |
| 11. | Cao, Y., Ma, J. (2011). Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila), 4, 486–501. DOI:10.1158/1940-6207.CAPR-10-0229. |
| 12. | Champ, C.E., Francis, L., Klement, R.J., Dickerman, R., Smith, R.P. (2016). Fortifying the treatment of prostate cancer with physical activity. Prostate Cancer, 2016, 9462975. DOI:10.1155/2016/9462975. |
| 13. | Chen, N., Zhou, Q. (2016). The evolving Gleason grading system. Chinese J Cancer Res, 28 (1), 58–64. DOI:10.3978/j.issn.1000-9604.2016.02.04. |
| 14. | Chen, Q., Chen, T., Shi, W., Zhang, T., Zhang, W., Jin, Z., Wei, X., Liu, Y., He, J. (2016). Adult weight gain and risk of prostate cancer: A dose-response meta-analysis of observational studies. Int J Cancer, 138 (4), 866–874. DOI:10.1002/ijc.29846. |
| 15. | De Cobelli, O., Terracciano, D., Tagliabue, E., Raimondi, S., Galasso, G., Cioffi, A. Cordima, G., Musi, G., Damiano, R., Cantiello, F., Detti, S., Victor Matei, D., Bottero, D., Renne, G., Ferro, M. (2015). Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance. Urol Oncol, 33 (5), 201.e1–8. DOI:10.1016/j.urolonc.2015.02.004. |
| 16. | De Pergola, G., Silvestris, F. (2013). Obesity as a major risk factor for cancer. J Obes, 2013, 291546. DOI:10.1155/2013/291546. |
| 17. | Deb, A.A., Emmanuel, O., Emara, S., Abbas, S.A. (2019). Physical activity and prostate cancer: a systematic review. Urol Nephrol Open Access J, 7 (5), 117–129. DOI:10.15406/unoaj.2019.07.00258. |
| 18. | Dickerman, B.A., Ahearn, T.U., Giovannucci, E., Stampfer, M.J., Nguyen, P.L., Mucci, L.A., Wilson, K.M. (2017). Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer. Int. J Cancer, 141 (5), 933–944. DOI:10.1002/ijc.30803. |
| 19. | Discacciati, A., Orsini, N., Wolk, A. (2012). Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies. Ann Oncol, 23 (7), 1665–1671. DOI:10.1093/annonc/mdr603. |
| 20. | Dobbins, M., Decorby, K., Choi, B.C. (2013). The association between obesity and cancer risk: A meta-analysis of observational studies from 1985 to 2011. ISRN Prev Med, 2013, 680536. DOI:10.5402/2013/680536. |
| 21. | Dutta, D., Ghosh, S., Pandit, K., Mukhopadhyay, P., Chowdhury, S. (2012). Leptin and cancer: Pathogenesis and modulation. Indian J Endocrinol Metab, 6 (Suppl 3), S596–600. DOI:10.4103/2230-8210.105577. |
| 22. | Egevad, L., Delahunt, B., Srigley, J.R., Samaratunga, H. (2016). International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading. APMIS, 124 (6), 433–435. DOI:10.1111/apm.12533. |
| 23. | Fang, H., Judd, R.L. (2018). Adiponectin regulation and function. Compr Physiol, 8 (3), 1031–1063. DOI:10.1002/cphy.c170046. |
| 24. | Ferro, M., Terracciano, D., Buonerba, C., Lucarelli, G., Bottero, D., Perdonà, S. Autorino, R., Serino, A., Cantiello, F., Damiano, R., Andras, I., De Placido, S., Di Lorenzo, G., Battaglia, M., Jereczek-Fossa, B. A., Mirone, V., De Cobelli, O. (2017). The emerging role of obesity, diet and lipid metabolism in prostate cancer. Future Oncol, 13 (3), 285–293. DOI:10.2217/fon-2016-0217. |
| 25. | Friedenreich, C. M., Stone, C. R., Cheung, W. Y., Hayes, S. C. (2019). Physical activity and mortality in cancer survivors: A systematic review and meta-analysis. JNCI Cancer Spectrum, 4 (1), pkz080. DOI:10.1093/jncics/pkz080. |
| 26. | Fujita, K., Hayashi, T., Matsushita, M., Uemura, M., Nonomura, N. (2019). Obesity, inflammation, and prostate cancer. J Clin Med, 8 (2), 201. DOI:10.3390/jcm8020201. |
| 27. | Gao, Q., Zheng, J., Yao, X., Peng, B. (2015). Adiponectin inhibits VEGF-A in prostate cancer cells. Tumour Biol, 36 (6), 4287–4292. DOI:10.1007/s13277-015-3067-1. |
| 28. | Giovannucci, E.L., Liu, Y., Leitzmann, M.F., Stampfer, M.J., Willett, W.C. (2005). A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med, 165 (9), 1005–1010. DOI:10.1001/archinte.165.9.1005. |
| 29. | Giovannucci, E., Liu, Y., Platz, E.A., Stampfer, M.J, Willett, W.C. (2007). Risk factors for prostate incidence and progression in the health professional’s follow-up study. Int J Cancer, 121, 1571–1578. DOI:10.1002/ijc.22788. |
| 30. | Grotta, A., Bottai, M., Adami, H.O., Adams, S.A., Akre, O., Blair, S.N., Mariosa, D., Nyrén, O., Ye, W., Stattin, P., Bellocco, R., Trolle Lagerros, Y. (2015). Physical activity and body mass index as predictors of prostate cancer risk. World J Urol, 33 (10), 1495–1502. DOI:10.1007/s00345-014-1464-5. |
| 31. | Heir, T., Falk, R.S., Robsahm, T.E., Sandvik, L., Erikssen, J., Tretli, S. (2016). Cholesterol and prostate cancer risk: a long-term prospective cohort study. BMC Cancer, 17 (16), 643. DOI:10.1186/s12885-016-2691-5. |
| 32. | Hojman, P., Gehl, J., Christensen, J.F., Pedersen, B.K. (2018). Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab, 27 (1), 10–21. DOI:10.1016/j.cmet.2017.09.015. |
| 33. | Holliday, A., Burgin, A., Fernandez, E.V., Fenton, S.A.M., Thielecke, F., Blannin, A.K. (2018). Points-based physical activity: a novel approach to facilitate changes in body composition in inactive women with overweight and obesity. BMC Public Health, 18, 261. DOI:10.1186/s12889-018-5125-2. |
| 34. | Hopkins, B.D., Goncalves, M.D., Cantley, L.C. (2016). Obesity and cancer mechanisms: cancer metabolism. J Clin Oncol, 34 (35), 4277–4283. DOI:10.1200/JCO.2016.67.9712 . |
| 35. | Hu, M.B., Bai, P.D., Wu, Y.S., Zhang, L.M., Xu, H., Na, R. Jiang, H. W., Ding, Q. (2015). Higher body mass index increases the risk for biopsy-mediated detection of prostate cancer in Chinese men. PLoS One, 10 (4), e0124668. DOI:10.1371/journal.pone.0124668. |
| 36. | Humphery, P.A. (2004). Gleason grading and prognostic factors in carcinoma of the prostate. Modem. Pathology, 17 (3), 292–306. DOI:10.1038/modpathol.3800054. |
| 37. | Hurwitz, L.M., Yeboah, E.D., Biritwum, R.B., Tettey, Y., Adjei, A.A., Mensah, J.E., Tay, E., Okyne, V., Truelove, A., Kelly, S. P., Zhou, C. K., Butler, E. N., Hoover, R. N., Hsing, A. W., Cook, M. B. (2020). Overall and abdominal obesity and prostate cancer risk in a West African population: An analysis of the Ghana Prostate Study. Int J Cancer, 147 (10), 2669–2676. DOI:10.1002/ijc.33026 |
| 38. | Jiang, W., Chen, B. (2017). Does body mass index correlate with the mortality of prostate cancer? A dose-response meta-analysis of cohort studies. Int J Clin Exp Med, 10 (1), 88–96. |
| 39. | Kelly, S.P., Graubard, B.I., Andreotti, G., Younes, N., Cleary, S.D., Cook, M.B. (2017). Prediagnostic body mass index trajectories in relation to prostate cancer incidence and mortality in the PLCO cancer screening trial. J Natl Cancer Inst, 109 (3), djw225. DOI:10.1093/jnci/djw225. |
| 40. | Kelly, S.P., Lennon, H., Sperrin, M., Matthews, C., Freedman, N.D., Albanes, D., Leitzmann, M. F., Renehan, A. G., Cook, M. B. (2019). Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: the NIH-AARP Diet and Health Study. Int J Epidemiol, 48 (2), 464–473. DOI:10.1093/ije/dyy219. |
| 41. | Kenfield, S.A., Stampfer, M.J., Giovannucci, E., Chan, J. M. (2011). Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol, 29 (6), 726–732. DOI:10.1200/JCO.2010.31.5226. |
| 42. | Kenfield, S.A., Van Blarigan, E.L., Panchal, N. Bang, A., Zhang, L., Graff, R. E., Chen, Y. H., Ryan, C. J., Luke, A., Newton, R. U., Tenggara, I., Schultz, B., Wang, E., Lavaki, E., Zuniga, K., Pinto, N., Borno, H., Aggarwal, R., Friedlander, T., Koshkin, V. S., … Chan, J. M. (2021). Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High-intensity Aerobic and resistance exercise for Metastatic castrate-resistant Prostate cancer. Cancer Med, 10 (22), 8058–8070. DOI:10.1002/cam4.4324. |
| 43. | Khan, S., Cai, J., Nielsen, M.E., Troester, M.A. Mohler, J. L., Fontham, E. T., Hendrix, L. H., Farnan, L., Olshan, A. F., & Bensen, J. T. (2016). The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study. Cancer Causes Control, 27 (12), 1475–1485. DOI:10.1007/s10552-016-0828-0. |
| 44. | Kim, B.Y., Choi, D.H., Jung, C.H., Kang, S.K., Mok, J.O., Kim, C.H. (2017). Obesity and physical activity. J Obes Metab Syndr, 26 (1), 15–22. DOI:10.7570/jomes.2017.26.1.15. |
| 45. | Klaunig, J.E., Kamendulis, L.M., Hocevar, B.A. (2010). Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol, 38, 96-109. DOI:10.1177/0192623309356453. |
| 46. | Koundouros, N., Poulogiannis, G. (2020). Reprogramming of fatty acid metabolism in cancer. British J Cancer, 122 (1), 4–22. DOI:10.1038/s41416-019-0650-z. |
| 47. | Kruk, J., Kotarska, K., Aboul-Enein, B.H. (2020). Physical exercise and catecholamines response: benefits and health risk: possible mechanisms. Free Radic Res, 54 (2–3), 105–125. DOI:10.1080/10715762.2020.1726343. |
| 48. | Kruk, J., Aboul-Enein, H.Y. (2016). What are the links of prostate cancer with physical activity and nutrition? A systematic review article. Iran J Public Health, 45 (12), 1558–1567. |
| 49. | Kruk, J., Aboul-Enein, H.Y. (2017). Reactive oxygen and nitrogen species in carcinogenesis: Implications of oxidative stress on the progression and development of several cancer types. Mini Rev Med Chem, 17, 904–19. DOI:10.2174/1389557517666170228115324. |
| 50. | Lakka, H.M., Bouchard, C. (2007). Etiology of obesity. In Surgical Management of Obesity, Buchwald, H., Cowan, C.S.M. Jr, Eds., Pories, pp. 455-471, Chap. 3. |
| 51. | Langlais, C.S., Cowan, J.E., Neuhaus, J., Kenfield, S.A., Van Blarigan, E.L., Broering, J.M., Cooperberg, M. R., Carroll, P., Chan, J. M. (2019). Obesity at diagnosis and prostate cancer prognosis and recurrence risk following primary treatment by radical prostatectomy. Cancer Epidemiol Biomarkers Prev, 28 (11), 1917–1925. https://doi.org/10.1158/1055-9965.EPI-19-0488 |
| 52. | Lavalette. C., Trétarre, B., Rebillard, X., Lamy, P.J., Cénée, S., Menegaux, F. (2018). Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study. Oncotarget, 9 (77), 34485–34494. DOI:10.18632/oncotarget.26128. |
| 53. | Lee, A., Chia, S.J. (2015). Prostate cancer detection: The impact of obesity on Asian men. Urol Oncol, 33 (6), 266.e17–22. DOI:10.1016/j.urolonc.2015.03.011. |
| 54. | Lee, J.H., Jun, H.S. (2019). Role of myokines in regulating skeletal muscle mass and function. Front Physiol, 10, 42. DOI:10.3389/fphys.2019.00042. |
| 55. | Littman, A.J., Kristal, A.R., White, E. (2006). Recreational physical activity and prostate cancer risk (United States). Cancer Causes Control, 17 (6), 831–841. DOI:10.1007/s10552-006-0024-8. |
| 56. | Liu, S., Lee, I.M., Linson, P., Ajani, U., Buring, J.E., Hennekens, C.H. (2000). A prospective study of physical activity and risk of prostate cancer in US physicians. Int J Epidemiol, 29 (1), 29–35. DOI:10.1093/ije/29.1.29. |
| 57. | Liu, Y., Hu, F., Li, D., Wang, F., Zhu, L., Chen, W., Ge, J., An, R., Zhao, Y. (2011). Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis. Eur Urol, 60 (5), 1029–1044. DOI:10.1016/j.eururo.2011.07.007. |
| 58. | Lynch, B.M. (2010). Sedentary behavior and cancer: a systematic review of the literature and proposed biological mechanisms. Cancer Epidemiol Biomarkers Prev, 19 (11), 2691–2709. https://doi.org/10.1158/1055-9965.EPI-10-0815 |
| 59. | MacInnis, R.J., English, D.R. (2006). Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control, 17, 989–1003. DOI: 10.1007/s10552-006-0049-z. |
| 60. | Mancuso P. (2016). The role of adipokines in chronic inflammation. Immunotargets Ther, 5, 47–56. DOI:10.2147/ITT.S73223. |
| 61. | McTiernan, A., Friedenreich, C.M., Katzmarzyk, P.T., Powell, K.E., Macko, R., Buchner, D., Pescatello, L.S., Bloodgood, B., Tennant, B., Vaux-Bjerke, A., George, S.M., Troiano, R.P., Piercy, K.L., 2018 PHYSICAL ACTIVITY GUIDELINES ADVISORY COMMITTEE (2019). Physical activity in cancer prevention and survival: A systematic review. Med Sci Sports Exerc, 51 (6), 1252–1261. DOI:10.1249/MSS.0000000000001937. |
| 62. | Melzer, K. (2011). Carbohydrate and fat utilization during rest and physical activity. E-spen Eur E-J Clin Nutr Metab, 6, e45–e52. DOI:10.1016/j.eclnm.2011.01.005. |
| 63. | Mohamad, H., McNeill, G., Haseen, F., N'Dow, J., Craig, L.C., Heys, S.D. (2015). The effect of dietary and exercise interventions on body weight in prostate cancer patients: a systematic review. Nutr Cancer, 67 (1), 43–60. DOI:10.1080/01635581.2015.976313. |
| 64. | Möller, E., Wilson, K.M., Batista, J.L., Mucci, L.A., Bälter, K., Giovannucci, E. (2016). Body size across the life course and prostate cancer in the Health Professionals Follow-up Study. Int J Cancer, 138 (4), 853–865. DOI:10.1002/ijc.29842. |
| 65. | Neton, R.U., Kenfield, S.A., Hart, N.H., Chan, J.M., Courneya, K.S., Catto, J., Finn, S. P., Greenwood, R., Hughes, D. C., Mucci, L., Plymate, S. R., Praet, S., Guinan, E. M., Van Blarigan, E. L., Casey, O., Buzza, M., Gledhill, S., Zhang, L., Galvão, D. A., Ryan, C. J., … Saad, F. (2018). Intense exercise for survival among men with metastatic castrate-resistant prostate cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol. BMJ Open, 8 (5), e022899. DOI:10.1136/bmjopen-2018-022899. |
| 66. | Obesity rates by country 2020 – World Population Review (2020) https://worldpopulationreview.com Accessed 4 January 2020. |
| 67. | Patel, A.V., Rodriguez, C., Jacobs, E.J., Solomon, L., Thun, M.J., Calle, E.E. (2005). Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men. Cancer Epidemiol Biomarkers Prev: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 14 (1), 275–279. |
| 68. | Perez-Cornago, A., Appleby, P.N., Pischon, T., Tsilidis, K.K., Tjønneland, A., Olsen, A., Overvad, K., Kaaks, R., Kühn, T., Boeing, H., Steffen, A., Trichopoulou, A., Lagiou, P., Kritikou, M., Krogh, V., Palli, D., Sacerdote, C., Tumino, R., Bueno-de-Mesquita, H. B., Agudo, A., … Travis, R. C. (2017). Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study. BMC Med, 15(1), 115. DOI:10.1186/s12916-017-0876-7. |
| 69. | Petridou, A., Siopi, A., Mougios, V. (2019). Exercise in the management of obesity. Metabolism, 92, 163–169. DOI:10.1016/j.metabol.2018.10.009. |
| 70. | Prostate Cancer Foundation. Curing Together (2022). Gleason Score and Grade Group. https://www.pcf.org. |
| 71. | Renehan, A.G., Zwahlen, M., Egger, M. (2015). Adiposity and cancer risk: new mechanistic insights from epidemiology. Nature Rev Cancer, 15 (8), 484–498. DOI:10.1038/nrc3967. |
| 72. | Renehan, A.G., Tyson, M., Egger, M., Heller, R.F. Zwahlen M. (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 371, 569–578. DOI:10.1016/S0140-6736(08)60269-X. |
| 73. | Richman, E.L., Kenfield, S.A., Stampfer, M.J., Paciorek, A., Carroll, P.R., Chan, J.M. (2011). Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res, 71 (11), 3889–3895. DOI:10.1158/0008-5472.CAN-10-3932. |
| 74. | Roberts, D.L., Dive, C., Renehan, A.G. (2010). Biological mechanisms linking obesity and cancer risk: new perspectives. Ann Rev Med, 61, 301–316. DOI:10.1146/annurev.med.080708.082713. |
| 75. | Rosenkilde, M., Auerbach, P., Reichkendler, M.H., Ploug, T., Stallknecht, B.M., Sjödin, A. (2012). Body fat loss and compensatory mechanisms in response to different doses of aerobic exercise - a randomized controlled trial in overweight sedentary males. Am J Physiol Regul Integr Comp Physiol, 303 (6), 571–579. DOI:10.1152/ajpregu.00141.2012. |
| 76. | Rowlands, M.A., Holly, J.M., Gunnell, D., Donovan, J., Lane, J.A., Hamdy, F., Neal, D. E., Oliver, S., Smith, G. D., & Martin, R. M. (2012). Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT. Cancer Res, 72 (2), 503–515. DOI:10.1158/0008-5472.CAN-11-1601. |
| 77. | Santoni, M., Cimadamore, A., Massari, F., Piva, F., Aurilio, G., Martignetti, A., Scarpelli, M., Di Nunno, V., Gatto, L., Battelli, N., Cheng, L., Lopez-Beltran, A., & Montironi, R. (2019). Key role of obesity in genitourinary tumors with emphasis on urothelial and prostate cancers. Cancers (Basel), 11 (9), 1225. DOI:10.3390/cancers11091225. |
| 78. | Severinsen, M.C.K., Pedersen, B.K. (2020). Muscle-organ crosstalk: The emerging roles of myokines. Endocr Rev, 41(4), 594-609. DOI:10.1210/endrev/bnaa016. |
| 79. | Smith, K.B., Smith, M.S. (2016). Obesity Statistics. Primary Care, 43 (1), 121–135. DOI:10.1016/j.pop.2015.10.001. |
| 80. | Thorogood, A., Mottillo, S., Shimony, A., Filion, K.B., Joseph, L., Genest, J., Pilote, L., Poirier, P., Schiffrin, E. L., Eisenberg, M. J. (2011). Isolated aerobic exercise and weight loss: a systematic review and meta-analysis of randomized controlled trials. Am J Med, 124 (8), 747–755. DOI:10.1016/j.amjmed.2011.02.037. |
| 81. | Trivedi, T., Samson, M., Orekoya, O. (2016). Obesity as a risk factor for prostate cancer: a clinical review. Integr Cancer Sci Ther, 3 (1), 366–369. DOI:10.15761/ICST.1000172. |
| 82. | Vidal, A.C., Freedland, S.J. (2017). Obesity and prostate cancer: A focused update on active surveillance, race, and molecular subtyping. Eur Urol, 72 (1), 78–83. DOI:10.1016/j.eururo.2016.10.011. |
| 83. | Vidal, A.C., Howard, L.E., Moreira, D.M., Castro-Santamaria, R., Andriole, G.L. Jr., Freedland, S.J. (2014). Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study. Cancer Epidemiol Biomarkers Prev, 23 (12), 2936–2942. DOI:10.1158/1055-9965.EPI-14-0795 |
| 84. | Vidal, A.C., Howard, L.E., Sun, S.X., Cooperberg, M.R., Kane, C.J., Aronson, W.J., Terris, M. K., Amling, C. L., Freedland, S. J. (2017). Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Prostate Cancer Prostatic Dis, 20 (1), 72–78. DOI:10.1038/pcan.2016.47. |
| 85. | Vidal, A.C., Oyekunle, T., Howard, L.E., De Hoedt, A.M., Kane, C.J., Terris, M.K., Cooperberg, M. R., Amling, C. L., Klaassen, Z., Freedland, S. J., Aronson, W. J. (2020). Obesity, race, and long-term prostate cancer outcomes. Cancer, 126 (16), 3733–3741. DOI:10.1002/cncr.32906. |
| 86. | WCRFI/AICR Continues Update Project. (2014). Report: Diet, Nutrition, Physical Activity, and Prostate Cancer http://www.wcrf.org/int/research-we-fund/continuous-update-project-findings-reports/prostate-cancer (accessed 11.11.2020). |
| 87. | Wekesa, A., Harrison, M., Watson, R.W. (2015). Physical activity and its mechanistic effects on prostate cancer. Prostate Cancer Prostatic Dis, 18 (3), 197–207. DOI:10.1038/pcan.2015.9. |
| 88. | Williams, G. (2012). Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-α and GPER signaling. Mol Cell Endocrinol, 351 (2), 269–278. DOI:10.1016/j.mce.2011.12.017. |
| 89. | World Cancer Research Fund International. Continuous Update Project. (2016). Cancer Prevention and Survival. Summary of global evidence on diet, weight, physical activity & what increases or decreases your risk of cancer. https//wwwcrforg/int/research-we-found/continuous-update-project-findings-reports/summary-global-evidence-cnacer (accessed 3.11.2020). |
| 90. | World Cancer Research Fund International/American Institute for Cancer Research (WCRFI/AICR), Continues Update Project (CUP) (2014). Report: Diet, Nutrition, Physical Activity, and Prostate Cancer 2014. Retrieved from www.wcrf.org/int/research-we-fund/continuous-update-project-findings-reports/prostate-cancer. |
| 91. | World Cancer Research Fund/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: A Global Perspective. Continuous Update Project Expert Report 2018. Available at dietandcancerreport.org. |
| 92. | World Health Organization (1997). Classification of overweight in adults according to BMI. In World Health Organization (Ed.), Obesity: Preventing and Managing the Global Epidemic. Geneva, Switzerland: World Health Organization. |
| 93. | World Health Organization 2018 February 16. https://www.linkedin.com/company/world-health-organization. |
| 94. | World Health Organization 2020. Global Strategy on Diet, Physical Activity & Health. What is moderate-intensity and vigorous-intensity physical activity? who.int/nmh/59/dpas/en/ (accessed 18.12.2020). |
| 95. | World Health Organization. Obesity and overweight. WHO https//www.who.int/mediacentre/factshits/fs3111/en/(2016). |
| 96. | Wu, V.J., Pang, D., Tang, W.W., Zhang, X., Li, L., You, Z. (2017). Obesity, age, ethnicity, and clinical features of prostate cancer patients. Am J Clin Exp Urol, 5 (1), 1–9. |
| 97. | Yu, Y.D., Byun, S.S., Lee, S.E., Hong, S.K. (2018). Impact of body mass index on oncological outcomes of prostate cancer patients after radical prostatectomy. Sci Rep, 8 (1), 11962. DOI:10.1038/s41598-018-30473-y. |
| 98. | Zeegers, M.P., Dirx, M.J., van den Brandt, P.A. (2005). Physical activity and the risk of prostate cancer in the Netherlands cohort study, results after 9.3 years of follow-up. Cancer Epidemiol Biomarkers Prev: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 14 (6), 1490–1495. DOI:10.1158/1055-9965.EPI-04-0771. |
| 99. | Zeigler-Johnson, C., Hudson, A., Glanz, K., Spangler, E., Morales, K.H. (2018). Performance of prostate cancer recurrence nomograms by obesity status: a retrospective analysis of a radical prostatectomy cohort. BMC Cancer, 18 (1), 1061. DOI:10.1186/s12885-018-4942-0. |
| 100. | Zhao, R., Cheng, G., Wang, B., Qin, C., Liu, Y., Pan, Y., Wang, J., Hua, L., Zhu, W., Wang, Z. (2017). BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people. Oncotarget, 8 (39), 66051–66060. DOI:10.18632/oncotarget.19790. |
| 101. | Zhong, S., Yan, X., Wu, Y., Zhang, X., Chen, L., Tang, J., Zhao, J. (2016). Body mass index and mortality in prostate cancer patients: a dose-response meta-analysis. Prostate Cancer Prostatic Dis, 19 (2), 122-131. DOI:10.1038/pcan.2015.64. |